About 4-[(E)-1-[3,5-bis(trifluoromethyl)piperidin-1-yl]-2-fluoroethenyl]morpholine
4-[(E)-1-[3,5-bis(trifluoromethyl)piperidin-1-yl]-2-fluoroethenyl]morpholine (PubChem CID 135169732) has the molecular formula C13H17F7N2O
and a molecular weight of 350.28 g/mol. Its IUPAC name is 4-[(E)-1-[3,5-bis(trifluoromethyl)piperidin-1-yl]-2-fluoroethenyl]morpholine.
Analyze 4-[(E)-1-[3,5-bis(trifluoromethyl)piperidin-1-yl]-2-fluoroethenyl]morpholine with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 4-[(E)-1-[3,5-bis(trifluoromethyl)piperidin-1-yl]-2-fluoroethenyl]morpholine?
The IUPAC name of 4-[(E)-1-[3,5-bis(trifluoromethyl)piperidin-1-yl]-2-fluoroethenyl]morpholine (CID 135169732) is 4-[(E)-1-[3,5-bis(trifluoromethyl)piperidin-1-yl]-2-fluoroethenyl]morpholine.
What is the SMILES notation for 4-[(E)-1-[3,5-bis(trifluoromethyl)piperidin-1-yl]-2-fluoroethenyl]morpholine?
The canonical SMILES for 4-[(E)-1-[3,5-bis(trifluoromethyl)piperidin-1-yl]-2-fluoroethenyl]morpholine is F/C=C(/N1CCOCC1)N1CC(C(F)(F)F)CC(C(F)(F)F)C1.
What is the InChIKey of 4-[(E)-1-[3,5-bis(trifluoromethyl)piperidin-1-yl]-2-fluoroethenyl]morpholine?
The InChIKey is WJGONBUYXLCEOJ-WDZFZDKYSA-N. The full InChI is InChI=1S/C13H17F7N2O/c14-6-11(21-1-3-23-4-2-21)22-7-9(12(15,16)17)5-10(8-22)13(18,19)20/h6,9-10H,1-5,7-8H2/b11-6-.
What are the key properties of 4-[(E)-1-[3,5-bis(trifluoromethyl)piperidin-1-yl]-2-fluoroethenyl]morpholine?
4-[(E)-1-[3,5-bis(trifluoromethyl)piperidin-1-yl]-2-fluoroethenyl]morpholine has a molecular weight of 350.28 g/mol, XLogP of 3.15, 2 rotatable bonds, 0 hydrogen bond donors, and 3 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[(E)-1-[3,5-bis(trifluoromethyl)piperidin-1-yl]-2-fluoroethenyl]morpholine is sourced from PubChem (CID 135169732), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).